Anastasia Dmitrieva
R-Pharm JSC, Russia
Biography
Anastasia Dmitrieva has 2 years of laboratory working experience (newly derived recombinant rubella vaccine development and characterization) and 4 years experience in nonclinical studies sphere. She has organized conduction of more than 40 nonclinical studies of different medicine group: small molecules, fusion proteins, monoclonal antibodies, biosimilars, and generics. Her activities include scientific support as well as new drug and biologics license application documents review. Her area of scientific interest includes Immunology, Immune-Oncology, Biology, Virology and Pharmacology.
Abstract
Abstract : Nonclinical characterization of the novel IL-1 heterodimeric fusion protein RPH-104